GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LUMOSA THERAPEUTICS CO LTD (ROCO:6535) » Definitions » Price-to-Tangible-Book

LUMOSA THERAPEUTICS CO (ROCO:6535) Price-to-Tangible-Book : 23.55 (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is LUMOSA THERAPEUTICS CO Price-to-Tangible-Book?

As of today (2024-05-25), LUMOSA THERAPEUTICS CO's share price is NT$184.50. LUMOSA THERAPEUTICS CO's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was NT$7.84. Hence, LUMOSA THERAPEUTICS CO's Price to Tangible Book Ratio of today is 23.55.

The historical rank and industry rank for LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6535' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.58   Med: 4.45   Max: 23.53
Current: 23.53

During the past 12 years, LUMOSA THERAPEUTICS CO's highest Price to Tangible Book Ratio was 23.53. The lowest was 2.58. And the median was 4.45.

ROCO:6535's Price-to-Tangible-Book is ranked worse than
95.99% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs ROCO:6535: 23.53

A closely related ratio is called PB Ratio. As of today, LUMOSA THERAPEUTICS CO's share price is NT$184.50. LUMOSA THERAPEUTICS CO's Book Value per Sharefor the quarter that ended in Mar. 2024 was NT$7.84. Hence, LUMOSA THERAPEUTICS CO's P/B Ratio of today is 23.54.


LUMOSA THERAPEUTICS CO Price-to-Tangible-Book Historical Data

The historical data trend for LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LUMOSA THERAPEUTICS CO Price-to-Tangible-Book Chart

LUMOSA THERAPEUTICS CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.76 3.68 3.16 4.01 8.05

LUMOSA THERAPEUTICS CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.83 6.22 6.82 8.05 22.78

Competitive Comparison of LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book

For the Biotechnology subindustry, LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book falls into.



LUMOSA THERAPEUTICS CO Price-to-Tangible-Book Calculation

LUMOSA THERAPEUTICS CO's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=184.50/7.836
=23.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


LUMOSA THERAPEUTICS CO Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of LUMOSA THERAPEUTICS CO's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


LUMOSA THERAPEUTICS CO (ROCO:6535) Business Description

Traded in Other Exchanges
N/A
Address
Yuanyuan Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503
LUMOSA THERAPEUTICS CO LTD develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of CNS, oncology, and inflammatory diseases. Geographically, it derives a majority of its revenue from Asia and also has a presence in Taiwan and America. Its product portfolio includes LT - 1001 and LT - 3001 for Analgesic Injection and Novel Small Molecules for the Treatment of Acute Ischemic Stroke.

LUMOSA THERAPEUTICS CO (ROCO:6535) Headlines

No Headlines